The Cognyte Story: The Most Undervalued Intelligence Company on Earth
The Setup
Imagine finding a company that does essentially what Palantir does — AI-powered investigative analytics for governments, military intelligence agencies, and national security organisations — but you’re paying 1.6x revenue instead of 130x. That’s not a typo. That’s Cognyte Software (NASDAQ: CGNT).
The stock sits around $8-9 today, with a market cap of roughly $610 million . The average 12-month analyst price target is $12-14, implying significant upside from current levels. But I believe the analysts are thinking far too small. Here’s why.
The Revenue Machine Is Accelerating
Cognyte isn’t a speculative pre-revenue startup. This is a battle-hardened, cash-generating machine that has been quietly compounding:
Q3 FY26 revenue hit $100.7 million, up 13.2% year-over-year, with year-to-date revenue reaching $293.8 million, up 14.7%.  The company raised full-year guidance to approximately $400 million in revenue, representing 14% growth, and adjusted EBITDA of approximately $47 million — a staggering 60% year-over-year increase. 
But here’s the number that should make every investor sit up: management has reiterated a $500 million revenue target for the fiscal year ending January 31, 2028.  That’s a clear roadmap from $400M to $500M in just two years — a 25% revenue increase with accelerating margin expansion.
Q1 FY26 alone showed revenue of $95.5 million (up 16%), non-GAAP operating income of $7.6 million (over 4x higher than the prior year), and deferred revenue of approximately $113 million  — a massive backlog that provides exceptional forward visibility.
A Contract Pipeline That Just Doesn’t Stop
The sheer volume and scale of contracts Cognyte has announced in 2025 alone is breathtaking:
In March 2025, Cognyte secured a three-year support agreement valued at over $20 million per year with a longstanding national security customer  — that’s $60M+ from a single client.
In May 2025, a new three-year subscription agreement valued at over $10 million annually with another national security customer in EMEA  — $30M+ locked in.
In October 2025, a follow-on contract worth over $5 million with a tier-1 military organisation in EMEA — the second major agreement with that customer in the same year, following an initial ~$10M contract signed earlier. 
In September 2025, a tier-1 national security agency renewed a $20M+ one-year support agreement — a customer relationship spanning over a decade. 
In November 2025, a new ~$5 million contract with a Tier-1 military intelligence organisation, where Cognyte was selected to replace the incumbent provider. 
Also in November, a new multi-unit win valued at approximately $5 million with a Tier-1 law enforcement agency across four agency units. 
And in the Asia-Pacific region, a follow-on agreement valued at over $5 million with a decade-long military intelligence customer, expanding deployment into additional frontline military units. 
This is a company winning and expanding contracts across every major geography — EMEA, Asia-Pacific, and increasingly, North America. The land-and-expand model is working, with customers deepening their investment year after year.
The US Market: The Game-Changer Nobody’s Pricing In
Here’s where the story gets truly explosive. Cognyte has been primarily an international business, but it is now making a deliberate, strategic push into the largest defence and intelligence market on the planet: the United States.
The LexisNexis Partnership
Cognyte signed a partnership with LexisNexis Risk Solutions, and the CEO stated clearly: “We have a lot of activities running with federal agencies in the US. If I have to summarize it, I really believe our upside opportunity is significant, and it’s not a matter of if, it’s a matter of when.” 
Cognyte has already conducted structured training for LexisNexis’s sales force, held joint customer meetings and events, and some of their sales teams are already actively engaging with customers about Cognyte’s offerings. 
Think about what this means. LexisNexis Risk Solutions already has deep, established relationships with virtually every law enforcement and federal agency in America. Cognyte is plugging directly into that distribution network. This is not a cold start — it’s an accelerated market entry with one of the most trusted names in US government data and analytics.
The GroupSense Acquisition
Cognyte acquired Virginia-based GroupSense, a digital risk protection company, with the CEO stating it would help establish global leadership in investigative analytics and expand its North American clientele.  The acquisition adds approximately 50 new US customers instantly. 
The US Opportunity in Context
The CEO has acknowledged that the US currently represents a small portion of revenue, but stated: “The U.S. represents a significant opportunity for us, given that it’s a large territory with many security agencies… We do believe that the U.S. will become a more significant portion of our business over time.” 
The US federal, state, and local law enforcement market for investigative analytics runs into the tens of billions. Even capturing a modest slice would transform Cognyte’s revenue trajectory. And with LexisNexis opening doors, the GroupSense acquisition providing a beachhead, and proof-of-concept engagements already running with federal agencies, the dominoes are falling.
Smart Money Has Done the Work
This isn’t retail speculation. Topline Capital Management, LLC is currently the company’s largest shareholder with 9.9% of shares outstanding.  They filed a Schedule 13G — not a 13D — which means this is a passive institutional investment acquired in the ordinary course of business. No activist agenda. Pure conviction.
Sitting right at the 9.9% threshold — the maximum passive ownership level before additional regulatory requirements kick in — tells you everything. This is a fund manager who has done exhaustive due diligence and concluded that Cognyte warrants one of the most concentrated positions possible without triggering control implications.
Topline has been consistently adding to its position, raising its stake by 2.4% in Q3 alone and now holding over 7.1 million shares.  At one point they owned over 9 million shares. This isn’t a trader flipping shares — this is deep, patient accumulation.
And they’re not alone. Edenbrook Capital and American Capital Management each hold approximately 9.3% of the company , meaning three dedicated funds together own roughly 28% of the entire company. The top 8 shareholders account for approximately 52% of the register.  Institutional ownership stands at approximately 75%. 
The float is getting tighter with every quarter. When the catalysts hit — and they will — the price moves will be amplified.
The Share Buyback: Management Betting on Themselves
In July 2025, Cognyte announced a brand new $20 million share repurchase programme after completing the previous $20 million buyback in full, having repurchased 2,094,538 ordinary shares.  That’s $40 million in total buyback capacity — extraordinary for a company of this size.
The new programme authorises buybacks through January 14, 2027, funded from existing cash and operational cash flow.  The board and management are not just talking about confidence — they’re putting capital behind it. Every share they buy back tightens the float further and increases your ownership stake in a growing business.
The Valuation Disconnect Is Absurd
Let’s talk numbers. Cognyte offers a compelling alternative to Palantir, trading at a bargain valuation and benefiting from similar public sector analytics tailwinds. 
At a ~$610M market cap and ~$400M in revenue guidance, you’re paying roughly 1.5x revenue for Cognyte. Palantir, operating in the same government analytics space, trades at approximately 60-130x revenue depending on the metric. Even applying a fraction of Palantir’s multiple to Cognyte implies a dramatically higher share price.
Cognyte holds more cash than debt on its balance sheet. Revenue is growing 14%+ year-over-year. EBITDA is growing 60%+ year-over-year. Billings are up 22% year-over-year. The company is transitioning to a subscription model, which means revenue quality is improving every quarter. Software revenue alone surged 39.6% year-over-year in Q3. 
And you’re getting all of this at a price-to-sales ratio that would be considered cheap for a no-growth utility company — let alone an AI-powered analytics firm winning multi-million-dollar contracts with the world’s most important intelligence agencies.
The Gartner Recognition
Cognyte was recognised as a Sample Vendor in the Gartner Hype Cycle for Public Safety and Law Enforcement, 2025 , and also in the Gartner Emerging Tech Impact Radar. This kind of analyst recognition matters enormously when government procurement teams are evaluating vendors. It validates Cognyte’s technology at the highest level and opens doors in enterprise sales cycles.
The Path to 2031: An Optimistic Scenario
Here’s where it gets exciting. Let me map out a realistic but optimistic trajectory:
Revenue Growth Path:
∙ FY26 (ending Jan 2026): ~$400M (confirmed guidance)
∙ FY28 (ending Jan 2028): ~$500M (management’s stated target)
∙ FY29-FY31: If the US market takes off via LexisNexis and organic growth, and international contracts continue compounding, a 15-20% annual growth rate is achievable
∙ By FY31 (ending Jan 2031): $750M - $1B in revenue
Margin Expansion:
∙ EBITDA margins are already expanding rapidly (from single digits to ~12% and climbing)
∙ As the subscription model scales and the US market generates higher-margin software revenue, EBITDA margins of 20-25% are realistic by 2031
∙ That implies $150M - $250M in EBITDA
Multiple Expansion:
∙ At $400M revenue today, Cognyte trades at ~1.5x revenue
∙ As the company proves its US growth story, transitions further to SaaS, and approaches profitability, a re-rating to 5-8x revenue is not unreasonable (still a fraction of Palantir’s multiple)
∙ Government analytics companies with proven growth and recurring revenue routinely trade at 6-10x revenue
The Math:
∙ Conservative case (5x on $750M revenue): $3.75B market cap → ~$51 per share
∙ Base case (6x on $850M revenue): $5.1B market cap → ~$70 per share
∙ Bull case (8x on $1B revenue, US market success): $8B market cap → ~$110 per share
Even the conservative scenario represents a 6x return from today’s price. The bull case? A potential 12-14x return.
Why I’m All In
This is one of those rare moments where everything aligns:
A company growing revenue at 14%+ with EBITDA growing at 60%+. An active $20M share buyback tightening the float. Smart money accumulating up to the maximum passive threshold. A strategic partnership with LexisNexis opening the gates to the world’s largest intelligence market. Multi-million-dollar contracts stacking up quarter after quarter. A management team that has laid out a clear $500M revenue roadmap. Gartner recognition validating the technology. And a valuation so disconnected from reality that you’re paying 1.5x for what could become a multi-billion-dollar enterprise.
The market hasn’t woken up yet. But between the institutional accumulation, the tightening float, the US market catalyst, and the relentless contract wins, it’s only a matter of time.
Optimistic share price target by 2031: $50-$110
This is generational. I’m all in. YOLO.
Disclaimer: This is a personal investment thesis, not financial advice. All investments carry risk, including the potential loss of principal. Do your own due diligence.
Have other thoughts on Cognyte Software?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
The user TheValueDetector has a position in NasdaqGS:CGNT. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.